Skip to main content
. 2018 Apr 3;8:5585. doi: 10.1038/s41598-018-23638-2

Figure 2.

Figure 2

Cumulative renal survival rates stratified according to TA-P in the adult HSPN patients. (A) ROC analysis of TA-P; (B) Renal survival rates from ESRD in two groups based on TA-P >1.0 g/day and TA-P <1.0 g/day; (C) Renal survival rates from ESRD or a 50% decline in renal function in three groups based on TA-P >1.0 g/day, 0.4–1.0 g/day and TA-P <0.4 g/day.